Moxifloxacin rescues SMA phenotypes in patient-derived cells and animal model.

While reporting a positive trend of increasing SMN protein levels in moxifloxacin mice (by 28%), the results with the gastrocnemius muscle were not significantly different between the two groups (Fig. 5 B).

also in 11,005 other papers